Effects from metal ion in tumor endothelial marker 8 and anthrax protective antigen: BioLayer Interferometry experiment and molecular dynamics simulation study

One of the anthrax receptors, tumor endothelial marker 8 (TEM8), is reported to be a potential anticancer target due to its over‐expression during tumor angiogenesis. To extend our BioLayer Interferometry study in PA‐TEM8 binding, we present a computational approach to reveal the role of an integral metal ion on receptor structure and binding thermodynamics. We estimated the interaction energy between PA and TEM8 using computer simulation. Consistent with experimental study, computational results indicate the metal ion in TEM8 contributes significantly to the binding affinity, and PA‐TEM8 binding is more favorable in the presence of Mg2+ than Ca2+. Further, computational analysis suggests that the differences in PA‐TEM8 binding affinity are comparable to the closely related integrin proteins. The conformation change, which linked to changes in activity of integrins, was not found in TEM8. In the present of Mg2+, TEM8 remains in a conformation analogous to an integrin open (high‐affinity) conformation. © 2017 Wiley Periodicals, Inc.

[1]  Mohammad Reza Abbaszadegan,et al.  Quantitative analysis of TEM-8 and CEA tumor markers indicating free tumor cells in the peripheral blood of colorectal cancer patients , 2011, International Journal of Colorectal Disease.

[2]  Ioan Andricioaei,et al.  Conversion between three conformational states of integrin I domains with a C-terminal pull spring studied with molecular dynamics. , 2004, Structure.

[3]  Brian N. Dominy,et al.  Analyzing the robustness of the MM/PBSA free energy calculation method: Application to DNA conformational transitions , 2011, J. Comput. Chem..

[4]  Robert C. Liddington,et al.  Crystal structure of a complex between anthrax toxin and its host cell receptor , 2004, Nature.

[5]  J. Mogridge,et al.  The Cytoplasmic Domain of Anthrax Toxin Receptor 1 Affects Binding of the Protective Antigen , 2008, Infection and Immunity.

[6]  Richard W. Farndale,et al.  Structural Basis of Collagen Recognition by Integrin α2β1 , 2000, Cell.

[7]  K. Sharp,et al.  Accurate Calculation of Hydration Free Energies Using Macroscopic Solvent Models , 1994 .

[8]  Lin Li,et al.  pKa predictions for proteins, RNAs, and DNAs with the Gaussian dielectric function using DelPhi pKa , 2015, Proteins.

[9]  K. Kinzler,et al.  Genes expressed in human tumor endothelium. , 2000, Science.

[10]  T. Caldwell,et al.  Identification of Small Molecules That Inhibit the Interaction of TEM8 with Anthrax Protective Antigen Using a FRET Assay , 2013, Journal of biomolecular screening.

[11]  R. Skeel,et al.  Langevin stabilization of molecular dynamics , 2001 .

[12]  Laxmikant V. Kalé,et al.  Scalable molecular dynamics with NAMD , 2005, J. Comput. Chem..

[13]  Carol Carter,et al.  TEM8 targeted cancer therapy. , 2011, Anti-cancer agents in medicinal chemistry.

[14]  R. Liddington,et al.  Crystal structure of the anthrax toxin protective antigen , 1997, Nature.

[15]  Li Zhang,et al.  Ligand Binding to Integrins* , 2000, The Journal of Biological Chemistry.

[16]  K. Klimpel,et al.  Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases , 1995, Infection and immunity.

[17]  B. Dominy,et al.  Development of a generalized Born model parameterization for proteins and nucleic acids , 1999 .

[18]  M. Karplus,et al.  CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .

[19]  Markus Meuwly,et al.  Study of the insulin dimerization: Binding free energy calculations and per‐residue free energy decomposition , 2005, Proteins.

[20]  Zihe Rao,et al.  The Structure of Tumor Endothelial Marker 8 (TEM8) Extracellular Domain and Implications for Its Receptor Function for Recognizing Anthrax Toxin , 2010, PloS one.

[21]  Manfred J. Sippl,et al.  A note on difficult structure alignment problems , 2008, Bioinform..

[22]  Philip K. Russell,et al.  Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. , 2000, JAMA.

[23]  D. Lacy,et al.  Binding Stoichiometry and Kinetics of the Interaction of a Human Anthrax Toxin Receptor, CMG2, with Protective Antigen* , 2004, Journal of Biological Chemistry.

[24]  D. Leahy,et al.  The role of the divalent cation in the structure of the I domain from the CD11a/CD18 integrin. , 1996, Structure.

[25]  Christian Kramer,et al.  MM/GBSA Binding Energy Prediction on the PDBbind Data Set: Successes, Failures, and Directions for Further Improvement , 2013, J. Chem. Inf. Model..

[26]  Kenneth A Bradley,et al.  Anthrax toxin receptor proteins. , 2003, Biochemical pharmacology.

[27]  S. Seaman,et al.  The cell surface structure of tumor endothelial marker 8 (TEM8) is regulated by the actin cytoskeleton. , 2011, Biochimica et biophysica acta.

[28]  J Y-Y Lee,et al.  Capillary morphogenesis gene‐2 mutation in infantile systemic hyalinosis: ultrastructural study and mutation analysis in a Taiwanese infant , 2005, Clinical and experimental dermatology.

[29]  Ron Elber,et al.  Revisiting Molecular Dynamics on a CPU/GPU system: Water Kernel and SHAKE Parallelization. , 2012, Journal of chemical theory and computation.

[30]  J. Clive,et al.  NIH research grants: funding and re-funding. , 2000, Journal of the American Medical Association (JAMA).

[31]  Raymond M Dawson.  The CMG2 ELISA for evaluating inhibitors of the binding of anthrax toxin protective antigen to its receptor. , 2009, Journal of pharmacological and toxicological methods.

[32]  M. Klein,et al.  Constant pressure molecular dynamics algorithms , 1994 .

[33]  Kenneth A Bradley,et al.  Anthrax toxin receptor 1/tumor endothelial marker 8: mutation of conserved inserted domain residues overrides cytosolic control of protective antigen binding. , 2010, Biochemistry.

[34]  M J Harvey,et al.  An Implementation of the Smooth Particle Mesh Ewald Method on GPU Hardware. , 2009, Journal of chemical theory and computation.

[35]  Barry C. Smith,et al.  Ionic radii for Group 1 and Group 2 halide, hydride, fluoride, oxide, sulfide, selenide and telluride crystals. , 2010, Dalton transactions.

[36]  Tingjun Hou,et al.  Assessing the Performance of the MM/PBSA and MM/GBSA Methods. 1. The Accuracy of Binding Free Energy Calculations Based on Molecular Dynamics Simulations , 2011, J. Chem. Inf. Model..

[37]  C. Brooks,et al.  Balancing solvation and intramolecular interactions: toward a consistent generalized Born force field. , 2006, Journal of the American Chemical Society.

[38]  Robert J. Linhardt,et al.  Binding between the Integrin αXβ2 (CD11c/CD18) and Heparin* , 2007, Journal of Biological Chemistry.

[39]  J. Apostolakis,et al.  Evaluation of a fast implicit solvent model for molecular dynamics simulations , 2002, Proteins.

[40]  Charles L. Brooks,et al.  Generalized born model with a simple smoothing function , 2003, J. Comput. Chem..

[41]  Alexander D. MacKerell,et al.  All-atom empirical potential for molecular modeling and dynamics studies of proteins. , 1998, The journal of physical chemistry. B.

[42]  L. Cryan,et al.  Targeting the anthrax receptors, TEM-8 and CMG-2, for anti-angiogenic therapy. , 2011, Frontiers in bioscience.

[43]  John A. Young,et al.  Crystal structure of the von Willebrand factor A domain of human capillary morphogenesis protein 2: an anthrax toxin receptor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[44]  B. St. Croix,et al.  Tumor endothelial markers: new targets for cancer therapy , 2004, Current opinion in oncology.

[45]  Junichi Takagi,et al.  Structures of the αL I Domain and Its Complex with ICAM-1 Reveal a Shape-Shifting Pathway for Integrin Regulation , 2003, Cell.

[46]  Annick Dejaegere,et al.  On the affinity regulation of the metal-ion-dependent adhesion sites in integrins. , 2006, Journal of the American Chemical Society.

[47]  Tiina A. Salminen,et al.  Jararhagin-derived RKKH Peptides Induce Structural Changes in α1I Domain of Human Integrin α1β1* , 2004, Journal of Biological Chemistry.

[48]  C L Brooks,et al.  Methodology for protein–ligand binding studies: Application to a model for drug resistance, the HIV/FIV protease system , 1999, Proteins.

[49]  A. Sali,et al.  Modeling of loops in protein structures , 2000, Protein science : a publication of the Protein Society.

[50]  R. Liddington,et al.  Crystal structure of the A domain from the a subunit of integrin CR3 (CD11 b/CD18) , 1995, Cell.

[51]  C. Brooks,et al.  An implicit membrane generalized born theory for the study of structure, stability, and interactions of membrane proteins. , 2003, Biophysical journal.

[52]  John A. Young,et al.  Interactions between anthrax toxin receptors and protective antigen. , 2005, Current opinion in microbiology.

[53]  John A. Young,et al.  Anthrax toxin: receptor binding, internalization, pore formation, and translocation. , 2007, Annual review of biochemistry.

[54]  Samuel Genheden,et al.  How to obtain statistically converged MM/GBSA results , 2009, J. Comput. Chem..

[55]  Samuel Genheden,et al.  A comparison of different initialization protocols to obtain statistically independent molecular dynamics simulations , 2011, J. Comput. Chem..

[56]  John A. Young,et al.  Identification of the cellular receptor for anthrax toxin , 2001, Nature.